OCS logo

Oculis Holding AG (OCS)

Profile

Full Name

Oculis Holding AG

Ticker Symbol

OCS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Switzerland

IPO

May 18, 2021

Indexes

Not included

Website

http://oculis.com

Employees

49

Key Details

Price

$16.75(+3.72%)

Market cap

$804.00M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.41(+27.18% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$16.75
OCS price is $16.75

30-Day Relative Volume

0.95
OCS 30-day relative volume is 0.95

Price Performance

Price Most recent change

+3.72%
OCS price was up +3.72% on Apr 11, 2025

Price YTD change

-1.47%
OCS price is down -1.47% since January 1st

Price 1-year change

+39.7%
OCS price is up +39.7% year-on-year

Price 3-year change

+71.27%
OCS price is up +71.27% over the past 3 years

Price Range

Price All-time high

$23.08
OCS price is currently -27.43% below its historical high of $23.08

Price 3-year low

$6.26
OCS price is currently +167.57% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$804.00M
OCS market capitalization is $804.00 million

Market cap 3-year change

-
OCS market capitalization 3-year change is unknown

Market cap All-time high

$1.03B
OCS market capitalization is currently -21.77% below its historical high of $1.03 billion

Market cap sector rank

74.77%
OCS market capitalization is higher than 74.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+30.65%
OCS shares outstanding is up +30.65% year-on-year

Shares Outstanding 3-Year Change

-
OCS shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.58
OCS beta is 0.58

200-day SMA

$15.87
OCS price is currently +5.52% above its 200-day simple moving average

50-day SMA

$19.53
OCS price is currently -14.24% below its 50-day simple moving average

RSI

40.92
OCS 14-day relative strength index is 40.92

Volume

0.95
OCS 30-day relative volume is 0.95

ATR

$1.00
OCS average true range is $1.00

10-day Historical Volatility

94.84%
OCS 10-day historical volatility is 94.84%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
OCS annual revenue value is unknown

Revenue Analysts estimate

$736.11K
OCS annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
OCS annual revenue 1-year change is unknown

Revenue Sector rank

-
OCS annual revenue is unknown

EPS

EPS

-$2.41
OCS annual earnings per share is -$2.41

EPS Analysts estimate

-$1.70
OCS annual earnings per share is currently +41.72% higher than the consensus analysts' forecast

EPS 1-year change

+27.18%
OCS annual earnings per share is up +27.18% year-on-year

EPS Sector rank

34.27%
OCS annual earnings per share is higher than 34.27% of companies in Healthcare sector

Profit

Gross profit

-
OCS annual gross profit value is unknown

Gross margin

-
OCS annual gross profit margin value is unknown

Operating profit

-$83.17M
OCS annual operating income is -$83.17 million

Operating margin

-
OCS annual operating profit margin value is unknown

Net income

-$97.46M
OCS annual net profit is -$97.46 million

Net margin

-
OCS annual net profit margin value is unknown

Expenses

Total expenses

$83.17M
OCS annual total expenses is $83.17 million

Operating expenses

$83.17M
OCS annual total operating expenses is $83.17 million

Cost of goods sold

-
OCS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$21.50M
OCS annual SGA is $21.50 million

Depreciation and amortization

$461.30K
OCS annual depreciation & amortization is $461.30 thousand

Interest expense

$726.00K
OCS annual interest expense is $726.00 thousand

Income tax

-$181.80K
OCS annual income tax is -$181.80 thousand

EBIT & EBITDA

EBIT

-$96.91M
OCS annual earnings before interest & taxes is -$96.91 million

EBITDA

-$96.45M
OCS annual EBITDA is -$96.45 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$133.20M
OCS annual total assets is $133.20 million

Non current assets

$17.11M
OCS annual long term assets is $17.11 million

Current assets

$116.10M
OCS annual total current assets is $116.10 million

Cash and cash equivalents

$30.67M
OCS annual cash & cash equivalents is $30.67 million

Accounts receivable

-
OCS annual accounts receivable value is unknown

Inventory

-
OCS annual inventory value is unknown

Liabilities

Total liabilities

$51.99M
OCS annual total liabilities is $51.99 million

Long term liabilities

$3.03M
OCS annual total long term liabilities is $3.03 million

Current liabilities

$48.96M
OCS annual total current liabilities is $48.96 million

Accounts payable

$6.50M
OCS annual accounts payable is $6.50 million

Debt

Total debt

$1.31M
OCS annual total debt is $1.31 million

Total debt 1-year change

+81.31%
OCS annual total debt is up +81.31% year-on-year

Long term debt

$957.40K
OCS annual long term debt is $957.40 thousand

Short term debt

$348.60K
OCS annual short term debt is $348.60 thousand

Equity & Capital

Shareholders equity

$81.22M
OCS annual stockholders equity is $81.22 million

Book value

$81.22M
OCS annual book value is $81.22 million

Retained earnings

-$316.05M
OCS annual retained earnings is -$316.05 million

Working capital

$67.14M
OCS annual working capital is $67.14 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$53.97M
OCS annual cash flow from operations is -$53.97 million

Cash from operations 1-year change

+10%
OCS annual cash flow from operations is up +10% year-on-year

Cash from investing

-$19.95M
OCS annual cash flow from investing activities is -$19.95 million

Cash from investing 1-year change

+66.96%
OCS annual cash flow from investing activities is up +66.96% year-on-year

Cash from financing

$61.39M
OCS annual cash flow from financing activities is $61.39 million

Cash from financing 1-year change

-57.49%
OCS annual cash flow from financing activities is down -57.49% year-on-year

CAPEX

CAPEX

-
OCS annual capital expenditures value is unknown

CAPEX 1-year change

-
OCS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$54.23M
OCS annual free cash flow is -$54.23 million

Free cash flow 1-year change

+9.65%
OCS annual free cash flow is up +9.65% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OCS annual gross profit margin value is unknown

Operating margin

-
OCS annual operating profit margin value is unknown

Net margin

-
OCS annual net profit margin value is unknown

ROA & ROE

ROA

-73.16%
OCS annual return on assets is -73.16%

ROE

-119.99%
OCS annual return on equity is -119.99%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OCS price to earnings ratio value is unknown

PE ratio Sector rank

-
OCS price to earnings ratio is unknown

PB Ratio

PB ratio

9.90
OCS price to book ratio is 9.90

PB ratio Sector rank

92.68%
OCS price to book ratio is higher than 92.68% of companies in Healthcare sector

PS Ratio

PS ratio

-
OCS price to sales ratio value is unknown

PS ratio Sector rank

-
OCS price to sales ratio is unknown

Enterprise value

Enterprise value

$774.64M
OCS enterprise value is $774.64 million

Enterprise value Sector rank

73.95%
OCS enterprise value is higher than 73.95% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.03
OCS EV/EBITDA is -8.03

EV/EBITDA Sector rank

12.85%
OCS EV/EBITDA is higher than 12.85% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.37
OCS annual current ratio is 2.37

Quick ratio

-
OCS annual quick ratio value is unknown

Leverage

Debt to equity

0.02
OCS annual debt to equity ratio is 0.02

Interest coverage ratio

-133.49
OCS annual interest coverage ratio is -133.49

Risk & Stability

Piotroski F-Score

-
OCS piotroski f-score value is unknown

Altman Z-Score

-
OCS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 13, 25 HC Wainwright & Co.
Buy
Mar 13, 25 Chardan Capital
Buy
Mar 13, 25 Baird
Outperform
Jan 7, 25 Chardan Capital
Buy
Jan 6, 25 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Oct 23, 24 HC Wainwright & Co.
Buy
Aug 28, 24 HC Wainwright & Co.
Buy
Jun 11, 24 HC Wainwright & Co.
Buy
Jun 11, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

ETNB logo
89bio (ETNB)
CMRX logo
Chimerix (CMRX)
ELVN logo
Enliven Therapeutics (ELVN)
DYN logo
Dyne Therapeutics (DYN)
GRAL logo
GRAIL (GRAL)
COLL logo
Collegium Pharmaceutical (COLL)
STAA logo
STAAR Surgical (STAA)
NTLA logo
Intellia Therapeutics (NTLA)
MLYS logo
Mineralys Therapeutics (MLYS)
  • What is the ticker symbol for Oculis Holding AG?
  • Does Oculis Holding AG pay dividends?
  • What sector is Oculis Holding AG in?
  • What industry is Oculis Holding AG in?
  • What country is Oculis Holding AG based in?
  • When did Oculis Holding AG go public?
  • Is Oculis Holding AG in the S&P 500?
  • Is Oculis Holding AG in the NASDAQ 100?
  • Is Oculis Holding AG in the Dow Jones?
  • When was Oculis Holding AG's last earnings report?
  • When does Oculis Holding AG report earnings?

What is the ticker symbol for Oculis Holding AG?

The ticker symbol for Oculis Holding AG is NASDAQ:OCS

Does Oculis Holding AG pay dividends?

No, Oculis Holding AG does not pay dividends

What sector is Oculis Holding AG in?

Oculis Holding AG is in the Healthcare sector

What industry is Oculis Holding AG in?

Oculis Holding AG is in the Biotechnology industry

What country is Oculis Holding AG based in?

Oculis Holding AG is headquartered in Switzerland

When did Oculis Holding AG go public?

Oculis Holding AG's initial public offering (IPO) was on May 18, 2021

Is Oculis Holding AG in the S&P 500?

No, Oculis Holding AG is not included in the S&P 500 index

Is Oculis Holding AG in the NASDAQ 100?

No, Oculis Holding AG is not included in the NASDAQ 100 index

Is Oculis Holding AG in the Dow Jones?

No, Oculis Holding AG is not included in the Dow Jones index

When was Oculis Holding AG's last earnings report?

Oculis Holding AG's most recent earnings report was on Mar 10, 2025

When does Oculis Holding AG report earnings?

The next expected earnings date for Oculis Holding AG is May 8, 2025
On this page